Related Experiment Videos
Skeletal metastasis from occult carcinoma
1Department of Orthopedics and Traumatology, Veterans General Hospital-Taipei, Taiwan, Republic of China.
Journal of Surgical Oncology
|October 1, 1992
Summary
Identifying the origin of bone metastases from unknown primary cancers is challenging, particularly in males. Early detection and targeted treatments are crucial for improving outcomes in patients with occult metastatic bone disease.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Skeletal metastases represent a significant clinical challenge, often originating from primary carcinomas that remain occult at diagnosis.
- Understanding the characteristics of these occult primary tumors is essential for improving patient management and outcomes.
Purpose of the Study:
- To define the clinical characteristics and outcomes of patients with skeletal metastases from occult primary carcinomas.
- To identify common features of occult primary tumors presenting as bone metastases.
- To evaluate the effectiveness of current treatment modalities.
Main Methods:
- Retrospective review of 177 patients with skeletal metastases diagnosed between 1984 and 1989.
- Analysis of patient demographics, symptoms, diagnostic evaluations, primary tumor identification, and survival data.
- Categorization of primary tumor sites and assessment of treatment responses.
Main Results:
- In 52% of patients, the primary carcinoma remained unidentified at initial diagnosis of bone metastases.
- The majority of patients with occult primaries were male, with intractable pain as the most common symptom.
- Lung, liver, and kidney were the most common primary sites identified; osteophilic nature, geographic incidence, and late detection were common features.
- Mean survival was 11 months; treatments were largely ineffective except for kidney and prostate primaries.
Conclusions:
- Diagnosing and treating skeletal metastases from occult primary carcinomas present significant challenges due to limitations in current diagnostic and therapeutic approaches.
- Focus should be on identifying common and treatable primary tumors early.
- Further research is needed to improve early detection and treatment strategies for these challenging cases.